Skip to main content

Is the Iran War Driving a Surge of Interest in Electric Cars?

1 week 4 days ago
In October and through November, America's EV sales reached their lowest point since 2022 after government subsidies expired, remembers Time. "But first-quarter data for 2026 shows that used EV sales were 12% higher than the same time last year and 17% higher than the previous quarter. "One factor likely helping push buyers toward these cars is high gas prices, which recently topped $4.00 a gallon for the first time in four years," they write — but it's not just in the U.S. Instead, they argue the U.S.-Iran conflict "is driving a global surge of interest in electric vehicles..." In the U.K., electric car sales reached a record high, with 86,120 vehicles sold in March... The French online used-car retailer Aramisauto reported its share of EV sales nearly doubled from February 16 to March 9, rising to 12.7% from 6.5%, while sales of fueled models dropped to 28% of sales from 34%, and sales of diesel models dropped to 10% from 14%. Germany's largest online car market, mobile.de, told Reuters that the share of EV searches on its website has tripled since the start of March — from 12% to 36%, with car dealers receiving 66% more enquiries for used EVs than in February. South Korea reported that registrations for electric vehicles more than doubled in March compared to the prior year, due in part to rising fuel prices and government subsidies... In New Zealand, more than 1,000 EVs were registered in the week that ended on March 22, close to double the week before, making it the country's biggest week for electric vehicle registrations since the end of 2023, according to the country's Transport Minister, Chris Bishop. In America, Bloomberg also reports 605 high-speed EV charging stations switched on in just the first three months of 2025, "a 34% increase over the year-earlier period," according to their analysis of federal data. A data platform focused on EV infrastructure tells Bloomberg that speedier and more reliable chargers are convincing more drivers to go electric and use public plugs.

Read more of this story at Slashdot.

EditorDavid

Pancreatic Cancer mRNA Vaccine Shows Lasting Results In Early Trial

1 week 5 days ago
NBC News reports on a 16-person clinical trial of "personalized messenger RNA vaccines" which use the immune system to fight cancer cells. "The goal is not to eliminate existing tumors, but instead to stamp out lingering, undetected cancer cells, and later any new cells that form before they can cause a recurrence." Patients still have surgery to remove tumors. After that, the mRNA vaccines are personalized for each individual using genetic material taken from their unique tumor cells. In the clinical trial, after getting the vaccine, the patients also received chemotherapy, which is standard post-op treatment for operable pancreatic cancer... [The article notes that less than 13% of people diagnosed with pancreatic cancer live for more than five years, making it "one of the deadliest cancers."] [E]xperts have long believed that people with pancreatic cancer could not generate an immune response against tumors. But after nine doses of the personalized vaccine, [clinical trial participant Donna] Gustafson is one of eight people in the 16-person Phase 1 trial who did just that, producing an army of immune cells called T cells that seek out and destroy tumor cells... [Dr. Vinod Balachandran, a vaccine center director who is leading the trial, said] it was unclear whether the immune response would last and lead to the patients living longer... New data collected during the trial's six-year follow-up period shows that it may. Those findings will be presented Monday at the American Association for Cancer Research's annual meeting in San Diego. Six years after treatment, Gustafson and six others who responded to the treatment are still alive... More research is still needed. Genentech and BioNTech, the two drugmakers behind the vaccine, have already launched a larger Phase 2 clinical trial... Another team is working on an off-the-shelf vaccine that targets a protein called KRAS that is present in as many as 90% of pancreatic cancers. In a small, early trial, about 85% of the participants mounted an immune response to the protein.

Read more of this story at Slashdot.

EditorDavid

Motorola Sues Social Media Platforms and Creators in India

1 week 5 days ago
"Motorola has filed a lawsuit in India against social media platforms and content creators," reports TechCrunch, "over posts it alleges are defamatory..." The lawsuit, filed in a Bengaluru court and obtained by TechCrunch, names platforms such as X, YouTube, and Instagram along with dozens of content creators, and seeks takedown of the content as well as broader restraint on what it describes as false or defamatory material related to the company's devices. In its over 60-page filing, Motorola has sought a permanent injunction restraining the defendants from publishing or sharing what it describes as false or defamatory content about its products, including reviews, videos, comments, and boycott campaigns. The complaint cites hundreds of posts across platforms, including videos alleging device issues and phones catching fire. But it is also targeting unfavorable product reviews and user commentary that the company alleges are false or defamatory. In a statement after publication, a Motorola spokesperson said it had initiated legal action "in the interest of public safety" against what it described as demonstrably false claims that its devices had exploded or caught fire. One online creator told TechCrunch "they expect more such legal action in the future, as evolving rules around online content increase liability for creators and platforms — a trend reflected in recently proposed changes to India's IT rules aimed at tightening oversight of online content." A Motorola spokesperson "said the company did not seek to suppress legitimate reviews or criticism and was reviewing the scope of the proceedings, adding that it apologized to creators affected inadvertently."

Read more of this story at Slashdot.

EditorDavid